SHE:002294 Revenue

Shenzhen Salubris Pharmaceuticals had revenue of 1.23B CNY in the quarter ending March 31, 2026, with 15.65% growth. This brings the company's revenue in the last twelve months to 4.52B, up 13.44% year-over-year. In the year 2025, Shenzhen Salubris Pharmaceuticals had annual revenue of 4.35B with 8.48% growth.

Revenue (ttm)

4.52B

Revenue Growth

+13.44%

P/S Ratio

13.49

Revenue / Employee

1.11M

Employees

3,596

Market Cap

60.96B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.35B	340.43M	8.48%
Dec 31, 2024	4.01B	646.89M	19.22%
Dec 31, 2023	3.37B	-116.67M	-3.35%
Jan 1, 2023	3.48B	423.62M	13.85%
Jan 1, 2022	3.06B	319.83M	11.68%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Huadong Medicine	44.06B
Shanghai Fosun Pharmaceutical (Group)	41.66B
Yunnan Baiyao Group Co.,Ltd	41.19B
China Resources Sanjiu Medical & Pharmaceutical	32.88B
Humanwell Healthcare (Group)	23.96B
Zhejiang NHU Company	22.25B
Beijing Tongrentang	17.26B
Changchun High-Tech Industry (Group)	11.67B

Revenue Rankings